Familial Polyposis Prognosis: Impact of Type, Timing, and Treatment

Familial polyposis syndromes carry a near-100% risk of colorectal cancer (CRC) if untreated. Prognosis hinges on early detection and intervention.

Types and Cancer Risk

SyndromeGenePolypsCRC RiskTypical Onset
Classic FAPAPC100s–1000s~100% by age 40Teens–20s
Attenuated FAP (AFAP)APC (distal)10–100~70% by age 7020s–40s
MUTYH-associated (MAP)MUTYH (biallelic)10–100s~43–100%40s–50s

Prognostic Factors

  • Age at diagnosis: Earlier → better surveillance window.
  • Polyp burden: Higher count → earlier colectomy.
  • Genotype: APC codon 1309 = severe; 5' end = attenuated.
  • Extracolonic manifestations: Desmoids, duodenal adenomas, thyroid cancer affect management.

Management and Outcomes

  • Surveillance: Annual colonoscopy from teens (FAP) or 20s (AFAP/MAP).
  • Prophylactic colectomy: Indicated when polyps too numerous/advanced. Options: IPAA (J-pouch) or IRA. Reduces CRC risk to <1%.
  • Duodenal surveillance: Upper endoscopy every 1–3 years (Spigelman staging).
  • Chemoprevention: Celecoxib/sulindac may reduce polyp burden (adjunct only).

With timely surgery and lifelong surveillance, life expectancy approaches normal. Multidisciplinary care (GI, genetics, surgery, psychology) is essential.

Genetic Disorders - Related Articles